Clinical trial
The Efficacy And Safety Of Lacidipine And Amlodipine Once-Daily Treatment In…
NCT00338338 · GlaxoSmithKline, Industry · Completed
Key facts
| NCT number | NCT00338338 |
|---|---|
| Title | The Efficacy And Safety Of Lacidipine And Amlodipine Once-Daily Treatment In Hypertensive Adult Patients |
| Official title | A Randomized, Double-blind, Parallel Group, Single-Centre Study to Evaluate the Efficacy and Safety of Lacidipine and Amlodipine Once-daily Treatment in Hypertensive Adult Patients |
| Lead sponsor | GlaxoSmithKline, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Uncomplicated Hypertension, Hypertension, Essential |
| Intervention type | Drug |
| Interventions | Lacidipine 4 or 6 mg (oral), Amlodipine 5 or 10 mg(oral) |
| Enrollment | 70 |
| Start date | Nov 7, 2005 |
| Primary completion | Sep 14, 2007 |
| Completion | Sep 14, 2007 |
| First posted | Jun 20, 2006 |
| Last update posted | Oct 9, 2017 |
| Countries | Taiwan |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: